FindTrial
Sign In

IN VITRO SUSCEPTIBILITY OF MOXIFLOXACIN OF THE MOST COMMON PATHOGENS OF THE RESPIRATORY SYSTEM REGIONAL STUDY IN LATIN AMERICA

IN VITRO SUSCEPTIBILITY OF MOXIFLOXACIN OF THE MOST COMMON PATHOGENS OF THE RESPIRATORY SYSTEM REGIONAL STUDY IN LATIN AMERICA

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
REPEC
Registry ID
PER-021-00
Enrollment
Unknown
Registered
2000-04-04
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

NA Type of group

Sponsors

BAYER S.A.,
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: NA

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

MeasureTime frame
Outcome name:NA Measure:NA Timepoints:NA—

Secondary

MeasureTime frame
Outcome name:NA Measure:NA Timepoints:NA—

Outcome results

None listed

Source: REPEC (via WHO ICTRP)